1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Biomedical Data Science
  4. Volume 6, 2023
  5. Article

Annual Review of Biomedical Data Science

Volume 6, 2023

Virus-Derived Small RNAs and microRNAs in Health and Disease

Abstract

MicroRNAs (miRNAs) are short noncoding RNAs that can regulate all steps of gene expression (induction, transcription, and translation). Several virus families, primarily double-stranded DNA viruses, encode small RNAs (sRNAs), including miRNAs. These virus-derived miRNAs (v-miRNAs) help the virus evade the host's innate and adaptive immune system and maintain an environment of chronic latent infection. In this review, the functions of the sRNA-mediated virus–host interactions are highlighted, delineating their implication in chronic stress, inflammation, immunopathology, and disease. We provide insights into the latest viral RNA–based research—in silico approaches for functional characterization of v-miRNAs and other RNA types. The latest research can assist toward the identification of therapeutic targets to combat viral infections.

Keyword(s): bioinformatics, Epstein–Barr virus, small RNAs, v-miRNAs, viral RNA bioinformatics resources, virally encoded microRNAs
Loading

Article metrics loading...

/content/journals/10.1146/annurev-biodatasci-122220-111429
2023-08-10
2024-04-29
Loading full text...

Full text loading...

/deliver/fulltext/biodatasci/6/1/annurev-biodatasci-122220-111429.html?itemId=/content/journals/10.1146/annurev-biodatasci-122220-111429&mimeType=html&fmt=ahah

Literature Cited

  1. 1.
    Stenglein MD. 2022. The case for studying new viruses of new hosts. Annu. Rev. Virol. 9:157–72
     [Google Scholar]
  2. 2.
    Lampson GP, Tytell AA, Field AK, Nemes MM, Hilleman MR. 1967. Inducers of interferon and host resistance. I. Double-stranded RNA from extracts of Penicillium funiculosum. PNAS 58:2782–89
     [Google Scholar]
  3. 3.
    Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80:105059–64
     [Google Scholar]
  4. 4.
    Crabtree A, Kizer E, Hunter S, Van Leuven J, New D et al. 2019. A rapid method for sequencing double-stranded RNAs purified from yeasts and the identification of a potent K1 killer toxin isolated from Saccharomyces cerevisiae. Viruses 11:70
     [Google Scholar]
  5. 5.
    Kobayashi K, Tomita R, Sakamoto M. 2009. Recombinant plant dsRNA-binding protein as an effective tool for the isolation of viral replicative form dsRNA and universal detection of RNA viruses. J. Gen. Plant Pathol. 75:287–91
     [Google Scholar]
  6. 6.
    Urayama S, Takaki Y, Hagiwara D, Nunoura T. 2020. dsRNA-seq reveals novel RNA virus and virus-like putative complete genome sequences from Hymeniacidon sp. sponge. Microb. Environ. 35:2ME19132
     [Google Scholar]
  7. 7.
    Decker CJ, Parker R. 2014. Analysis of dsRNA from microbial communities identifies dsRNA virus-like elements. Cell Rep. 7:3898–906
     [Google Scholar]
  8. 8.
    Gao Y, Chen S, Halene S, Tebaldi T. 2021. Transcriptome-wide quantification of double-stranded RNAs in live mouse tissues by dsRIP-Seq. STAR Protoc. 2:100366
     [Google Scholar]
  9. 9.
    Niu D-K, Jiang L. 2013. Can ENCODE tell us how much junk DNA we carry in our genome?. Biochem. Biophys. Res. Commun. 430:41340–43
     [Google Scholar]
  10. 10.
    Int. Hum. Genome Seq. Consort 2004. Finishing the euchromatic sequence of the human genome. Nature 431:7011931–45
     [Google Scholar]
  11. 11.
    Dhanoa JK, Sethi RS, Verma R, Arora JS, Mukhopadhyay CS. 2018. Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review. J. Anim. Sci. Technol. 60:25
     [Google Scholar]
  12. 12.
    Fernandes JCR, Acuña SM, Aoki JI, Floeter-Winter LM, Muxel SM. 2019. Long non-coding RNAs in the regulation of gene expression: physiology and disease. Noncod. RNA 5:17
     [Google Scholar]
  13. 13.
    Chew CL, Conos SA, Unal B, Tergaonkar V. 2018. Noncoding RNAs: master regulators of inflammatory signaling. Trends Mol. Med. 24:66–84
     [Google Scholar]
  14. 14.
    Agrawal N, Dasaradhi PVN, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK. 2003. RNA interference: biology, mechanism, and applications. Microbiol. Mol. Biol. Rev. 67:4657–85
     [Google Scholar]
  15. 15.
    Carthew RW, Sontheimer EJ. 2009. Origins and mechanisms of miRNAs and siRNAs. Cell 136:4642–55
     [Google Scholar]
  16. 16.
    Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:6669806–11
     [Google Scholar]
  17. 17.
    Grimson A, Srivastava M, Fahey B, Woodcroft BJ, Chiang HR et al. 2008. Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals. Nature 455:72171193–97
     [Google Scholar]
  18. 18.
    Wianny F, Zernicka-Goetz M. 2000. Specific interference with gene function by double-stranded RNA in early mouse development. Nat. Cell Biol. 2:270–75
     [Google Scholar]
  19. 19.
    Zhou R, Rana TM. 2013. RNA-based mechanisms regulating host–virus interactions. Immunol. Rev. 253:97–111
     [Google Scholar]
  20. 20.
    Ha M, Kim VN. 2014. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 15:8509–24
     [Google Scholar]
  21. 21.
    Schwarz DS, Hutvágner G, Du T, Xu Z, Aronin N, Zamore PD. 2003. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115:2199–208
     [Google Scholar]
  22. 22.
    Friedman RC, Farh KK-H, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19:92–105
     [Google Scholar]
  23. 23.
    Han T-S, Hur K, Cho H-S, Ban HS. 2020. Epigenetic associations between lncRNA/circRNA and miRNA in hepatocellular carcinoma. Cancers 12:92622
     [Google Scholar]
  24. 24.
    Ebert MS, Sharp PA. 2012. Roles for MicroRNAs in conferring robustness to biological processes. Cell 149:3515–24
     [Google Scholar]
  25. 25.
    Weber F, Kochs G, Haller O. 2004. Inverse interference: how viruses fight the interferon system. Viral Immunol. 17:4498–515
     [Google Scholar]
  26. 26.
    Carl JW, Trgovcich J, Hannenhalli S. 2013. Widespread evidence of viral miRNAs targeting host pathways. BMC Bioinform. 14:Suppl. 2S3
     [Google Scholar]
  27. 27.
    Mishra R, Kumar A, Ingle H, Kumar H. 2020. The interplay between viral-derived miRNAs and host immunity during infection. Front. Immunol. 10:3079
     [Google Scholar]
  28. 28.
    Grundhoff A, Sullivan CS. 2011. Virus-encoded microRNAs. Virology 411:2325–43
     [Google Scholar]
  29. 29.
    Farrell PJ. 2018. Epstein–Barr virus and cancer. Annu. Rev. Pathol. 14:29–53
     [Google Scholar]
  30. 30.
    Draborg AH, Duus K, Houen G. 2012. Epstein-Barr virus and systemic lupus erythematosus. Clin. Dev. Immunol. 2012:370516
     [Google Scholar]
  31. 31.
    Barcelos F, Martins C, Monteiro R, Cardigos J, Prussiani T et al. 2021. Association between EBV serological patterns and lymphocytic profile of SjS patients support a virally triggered autoimmune epithelitis. Sci. Rep. 11:4082
     [Google Scholar]
  32. 32.
    Balandraud N, Roudier J. 2018. Epstein-Barr virus and rheumatoid arthritis. Joint Bone Spine 85:2165–70
     [Google Scholar]
  33. 33.
    Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ et al. 2022. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375:6578296–301
     [Google Scholar]
  34. 34.
    Murata T, Tsurumi T. 2014. Switching of EBV cycles between latent and lytic states: regulation of EBV reactivation. Rev. Med. Virol. 24:3142–53
     [Google Scholar]
  35. 35.
    Sausen D, Bhutta M, Gallo E, Dahari H, Borenstein R. 2021. Stress-induced Epstein-Barr virus reactivation. Biomolecules 11:91380
     [Google Scholar]
  36. 36.
    Pfeffer S, Zavolan M, Grässer FA, Chien M, Russo JJ et al. 2004. Identification of virus-encoded microRNAs. Science 304:5671734–36
     [Google Scholar]
  37. 37.
    Grundhoff A, Sullivan CS, Ganem D. 2006. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12:5733–50
     [Google Scholar]
  38. 38.
    Klinke O, Feederle R, Delecluse H-J. 2014. Genetics of Epstein–Barr virus microRNAs. Semin. Cancer Biol. 26:52–59
     [Google Scholar]
  39. 39.
    Wang M, Gu B, Chen X, Wang Y, Li P, Wang K. 2019. The function and therapeutic potential of Epstein-Barr virus-encoded microRNAs in cancer. Mol. Ther. Nucleic Acids 17:657–68
     [Google Scholar]
  40. 40.
    Anand L, Rodriguez Lopez CM. 2022. ChromoMap: an R package for interactive visualization of multi-omics data and annotation of chromosomes. BMC Bioinform. 23:33
     [Google Scholar]
  41. 41.
    Dölken L, Malterer G, Erhard F, Kothe S, Friedel CC et al. 2010. Systematic analysis of viral and cellular microRNA targets in cells latently infected with human γ-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7:4324–34
     [Google Scholar]
  42. 42.
    Cai L-M, Lyu X-M, Luo W-R, Cui X-F, Ye Y-F et al. 2015. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene 34:172156–66
     [Google Scholar]
  43. 43.
    Cai L, Li J, Zhang X, Lu Y, Wang J et al. 2015. Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma. Oncotarget 6:107838–50
     [Google Scholar]
  44. 44.
    Iizasa H, Wulff B-E, Alla NR, Maragkakis M, Megraw M et al. 2010. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J. Biol. Chem. 285:4333358–70
     [Google Scholar]
  45. 45.
    Lu Y, Qin Z, Wang J, Zheng X, Lu J et al. 2017. Epstein-Barr virus miR-BART6-3p inhibits the RIG-I pathway. J. Innate Immun. 9:6574–86
     [Google Scholar]
  46. 46.
    Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K et al. 2007. Epstein–Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res. 36:2666–75
     [Google Scholar]
  47. 47.
    Lo AKF, To KF, Lo KW, Lung RWM, Hui JWY et al. 2007. Modulation of LMP1 protein expression by EBV-encoded microRNAs. PNAS 104:4116164–69
     [Google Scholar]
  48. 48.
    Nahand JS, Mahjoubin-Tehran M, Moghoofei M, Pourhanifeh MH, Mirzaei HR et al. 2020. Exosomal miRNAs: novel players in viral infection. Epigenomics 12:4353–70
     [Google Scholar]
  49. 49.
    Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MAJ, Hopmans ES et al. 2010. Functional delivery of viral miRNAs via exosomes. PNAS 107:146328–33
     [Google Scholar]
  50. 50.
    Haneklaus M, Gerlic M, Kurowska-Stolarska M, Rainey A-A, Pich D et al. 2012. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production. J. Immunol. 189:83795–99
     [Google Scholar]
  51. 51.
    Yogev O, Henderson S, Hayes MJ, Marelli SS, Ofir-Birin Y et al. 2017. Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAs. PLOS Pathog. 13:8e1006524
     [Google Scholar]
  52. 52.
    Swaminathan G, Martin-Garcia J, Navas-Martin S. 2013. RNA viruses and microRNAs: challenging discoveries for the 21st century. Physiol. Genom. 45:221035–48
     [Google Scholar]
  53. 53.
    Nanbo A, Furuyama W, Lin Z. 2021. RNA virus-encoded miRNAs: current insights and future challenges. Front. Microbiol. 12:679210
     [Google Scholar]
  54. 54.
    Nisole S, Saïb A. 2004. Early steps of retrovirus replicative cycle. Retrovirology 1:9
     [Google Scholar]
  55. 55.
    Bennasser Y, Le S-Y, Yeung M, Jeang K-T. 2004. HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology 1:43
     [Google Scholar]
  56. 56.
    Omoto S, Ito M, Tsutsumi Y, Ichikawa Y, Okuyama H et al. 2004. HIV-1 nef suppression by virally encoded microRNA. Retrovirology 1:44
     [Google Scholar]
  57. 57.
    Bennasser Y, Le S-Y, Benkirane M, Jeang K-T. 2005. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22:5607–19
     [Google Scholar]
  58. 58.
    Schopman NCT, Willemsen M, Liu YP, Bradley T, van Kampen A et al. 2012. Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res. 40:414–27
     [Google Scholar]
  59. 59.
    Lefebvre G, Desfarges S, Uyttebroeck F, Muñoz M, Beerenwinkel N et al. 2011. Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell. J. Virol. 85:136205–11
     [Google Scholar]
  60. 60.
    Dolja VV, Koonin EV. 2018. Metagenomics reshapes the concepts of RNA virus evolution by revealing extensive horizontal virus transfer. Virus Res. 244:36–52
     [Google Scholar]
  61. 61.
    Riley KJ-L, Rabinowitz GS, Steitz JA. 2010. Comprehensive analysis of rhesus lymphocryptovirus microRNA expression. J. Virol. 84:105148–57
     [Google Scholar]
  62. 62.
    Rosa MD, Gottlieb E, Lerner MR, Steitz JA. 1981. Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol. Cell. Biol. 1:785–96
     [Google Scholar]
  63. 63.
    Lee N, Pimienta G, Steitz JA. 2012. AUF1/hnRNP D is a novel protein partner of the EBER1 noncoding RNA of Epstein-Barr virus. RNA 18:112073–82
     [Google Scholar]
  64. 64.
    Schwemmle M, Clemens MJ, Hilse K, Pfeifer K, Tröster H et al. 1992. Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells. PNAS 89:2110292–96
     [Google Scholar]
  65. 65.
    Sharp TV, Schwemmle M, Jeffrey I, Laing K, Mellor H et al. 1993. Comparative analysis of the regulation of the interferoninducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VA, RNA. Nucleic Acids Res. 21:194483–90
     [Google Scholar]
  66. 66.
    Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K. 2006. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 25:184207–14
     [Google Scholar]
  67. 67.
    Baglio SR, van Eijndhoven MAJ, Koppers-Lalic D, Berenguer J, Lougheed SM et al. 2016. Sensing of latent EBV infection through exosomal transfer of 5′pppRNA. PNAS 113:5E587–96
     [Google Scholar]
  68. 68.
    Ahmed W, Tariq S, Khan G. 2018. Tracking EBV-encoded RNAs (EBERs) from the nucleus to the excreted exosomes of B-lymphocytes. Sci. Rep. 8:15438
     [Google Scholar]
  69. 69.
    Iwakiri D, Zhou L, Samanta M, Matsumoto M, Ebihara T et al. 2009. Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3. J. Exp. Med. 206:102091–99
     [Google Scholar]
  70. 70.
    Lerner MR, Andrews NC, Miller G, Steitz JA. 1981. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. PNAS 78:2805–9
     [Google Scholar]
  71. 71.
    Fournier B, Boutboul D, Bruneau J, Miot C, Boulanger C et al. 2020. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection. J. Exp. Med. 217:11e20192262
     [Google Scholar]
  72. 72.
    Nachmani D, Lankry D, Wolf DG, Mandelboim O. 2010. The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nat. Immunol. 11:9806–13
     [Google Scholar]
  73. 73.
    Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Biton M et al. 2015. Host immune system gene targeting by a viral miRNA. Science 317:5836376–81
     [Google Scholar]
  74. 74.
    Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N et al. 2011. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 9:293–102
     [Google Scholar]
  75. 75.
    Callegari S, Gastaldello S, Faridani OR, Masucci MG. 2014. Epstein-Barr virus encoded microRNAs target SUMO-regulated cellular functions. FEBS J. 281:214935–50
     [Google Scholar]
  76. 76.
    Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E et al. 2008. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1–3. Cancer Res. 68:51436–42
     [Google Scholar]
  77. 77.
    Skinner CM, Ivanov NS, Barr SA, Chen Y, Skalsky RL. 2017. An Epstein-Barr virus microRNA blocks interleukin-1 (IL-1) signaling by targeting IL-1 receptor 1. J. Virol. 91:21e00530–17
     [Google Scholar]
  78. 78.
    Hooykaas MJG, van Gent M, Soppe JA, Kruse E, Boer IGJ et al. 2017. EBV microRNA BART16 suppresses type I IFN signaling. J. Immunol. 198:104062–73
     [Google Scholar]
  79. 79.
    Zhang Y-M, Yu Y, Zhao H-P. 2017. EBV-BART-6-3p and cellular microRNA-197 compromise the immune defense of host cells in EBV-positive Burkitt lymphoma. Mol. Med. Rep. 15:41877–83
     [Google Scholar]
  80. 80.
    Qin Z, Kearney P, Plaisance K, Parsons CH. 2010. Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J. Leukocyte Biol. 87:25–34
     [Google Scholar]
  81. 81.
    Yang L, Aozasa K, Oshimi K, Takada K. 2004. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res 64:155332–37
     [Google Scholar]
  82. 82.
    Tastsoglou S, Miliotis M, Kavakiotis I, Alexiou A, Gkotsi EC et al. 2021. PlasmiR: a manual collection of circulating microRNAs of prognostic and diagnostic value. Cancers 13:153680
     [Google Scholar]
  83. 83.
    Huang Z, Shi J, Gao Y, Cui C, Zhang S et al. 2019. HMDD v3.0: a database for experimentally supported human microRNA-disease associations. Nucleic Acids Res. 47:D1D1013–17
     [Google Scholar]
  84. 84.
    Loureiro D, Tout I, Narguet S, Benazzouz SM, Mansouri A, Asselah T. 2020. miRNAs as potential biomarkers for viral hepatitis B and C. Viruses 12:121440
     [Google Scholar]
  85. 85.
    Madè A, Greco S, Vausort M, Miliotis M, Schordan E et al. 2022. Association of miR-144 levels in the peripheral blood with COVID-19 severity and mortality. Sci. Rep. 12:20048
     [Google Scholar]
  86. 86.
    Kincaid RP, Sullivan CS. 2012. Virus-encoded microRNAs: an overview and a look to the future. PLOS Pathog. 8:12e1003018
     [Google Scholar]
  87. 87.
    Lindow M, Kauppinen S. 2012. Discovering the first microRNA-targeted drug. J. Cell Biol. 199:3407–12
     [Google Scholar]
  88. 88.
    Gebert LFR, Rebhan MAE, Crivelli SEM, Denzler R, Stoffel M, Hall J. 2014. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res. 42:609–21
     [Google Scholar]
  89. 89.
    Janssen HLA, Zeuzem S. 2013. Treatment of HCV infection by targeting microRNA. New Engl. J. Med. 368:181685–94
     [Google Scholar]
  90. 90.
    van der Ree MH, de Vree JM, Stelma F, Willemse S, van der Valk M et al. 2017. Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial. Lancet 389:10070709–17
     [Google Scholar]
  91. 91.
    Morais P, Adachi H, Yu Y-T. 2021. The critical contribution of pseudouridine to mRNA COVID-19 vaccines. Front. Cell Dev. Biol. 9:789427
     [Google Scholar]
  92. 92.
    Karikó K, Muramatsu H, Welsh FA, Ludwig J, Kato H et al. 2008. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16:111833–40
     [Google Scholar]
  93. 93.
    Anderson BR, Muramatsu H, Nallagatla SR, Bevilacqua PC, Sansing LH et al. 2010. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38:175884–92
     [Google Scholar]
  94. 94.
    Boccaletto P, Stefaniak F, Ray A, Cappannini A, Mukherjee S et al. 2022. MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res. 50:D1D231–35
     [Google Scholar]
  95. 95.
    Garbo S, Maione R, Tripodi M, Battistelli C. 2022. Next RNA therapeutics: the mine of non-coding. Int. J. Mol. Sci. 23:137471
     [Google Scholar]
  96. 96.
    Althurwi HN, Alharthy KM, Albaqami FF, Altharawi A, Javed MR et al. 2022. mRNA-based vaccine designing against Epstein-Barr virus to induce an immune response using immunoinformatic and molecular modelling approaches. Int. J. Environ. Res. Public Health 19:2013054
     [Google Scholar]
  97. 97.
    Huo H, Hu G. 2019. CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth. Infect. Agents Cancer 14:30
     [Google Scholar]
  98. 98.
    Akidil E, Albanese M, Buschle A, Ruhle A, Pich D et al. 2021. Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection. PLOS Pathog. 17:4e1009117
     [Google Scholar]
  99. 99.
    Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. 2005. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435:7042682–86
     [Google Scholar]
  100. 100.
    Castelli M, Sekanina L, Zhang M, Cagnoni S, García-Sánchez P, eds. 2018. Genetic Programming: Proceedings of the 21st European Conference (EuroGP 2018) Cham, Switz.: Springer Int.
  101. 101.
    Glazov EA, Horwood PF, Assavalapsakul W, Kongsuwan K, Mitchell RW et al. 2010. Characterization of microRNAs encoded by the bovine herpesvirus 1 genome. J. Gen. Virol. 91:32–41
     [Google Scholar]
  102. 102.
    Besecker MI, Harden ME, Li G, Wang X-J, Griffiths A. 2009. Discovery of herpes B virus-encoded microRNAs. J. Virol. 83:73413–16
     [Google Scholar]
  103. 103.
    Cui C, Griffiths A, Li G, Silva LM, Kramer MF et al. 2006. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J. Virol. 80:115499–508
     [Google Scholar]
  104. 104.
    Timoneda O, Núñez-Hernández F, Balcells I, Muñoz M, Castelló A et al. 2014. The role of viral and host microRNAs in the Aujeszky's disease virus during the infection process. PLOS ONE 9:e86965
     [Google Scholar]
  105. 105.
    Jurak I, Kramer MF, Mellor JC, van Lint AL, Roth FP et al. 2010. Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2. J. Virol. 84:94659–72
     [Google Scholar]
  106. 106.
    Waidner LA, Morgan RW, Anderson AS, Bernberg EL, Kamboj S et al. 2009. MicroRNAs of Gallid and Meleagrid herpesviruses show generally conserved genomic locations and are virus-specific. Virology 388:128–36
     [Google Scholar]
  107. 107.
    Yao Y, Smith LP, Petherbridge L, Watson M, Nair V. 2012. Novel microRNAs encoded by duck enteritis virus. J. Gen. Virol. 93:71530–36
     [Google Scholar]
  108. 108.
    Kincaid RP, Burke JM, Sullivan CS. 2012. RNA virus microRNA that mimics a B-cell oncomiR. PNAS 109:83077–82
     [Google Scholar]
  109. 109.
    Rosewick N, Momont M, Durkin K, Takeda H, Caiment F et al. 2013. Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma. PNAS 110:62306–11
     [Google Scholar]
  110. 110.
    Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C et al. 2005. Identification of microRNAs of the herpesvirus family. Nat. Methods 2:4269–76
     [Google Scholar]
  111. 111.
    Rachamadugu R, Lee JY, Wooming A, Kong B-W. 2009. Identification and expression analysis of infectious laryngotracheitis virus encoding microRNAs. Virus Genes 39:3301–8
     [Google Scholar]
  112. 112.
    Dölken L, Perot J, Cognat V, Alioua A, John M et al. 2007. Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J. Virol. 81:2413771–82
     [Google Scholar]
  113. 113.
    Yao Y, Zhao Y, Xu H, Smith LP, Lawrie CH et al. 2007. Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1. J. Virol. 81:137164–70
     [Google Scholar]
  114. 114.
    Reese TA, Xia J, Johnson LS, Zhou X, Zhang W, Virgin HW. 2010. Identification of novel microRNA-like molecules generated from herpesvirus and host tRNA transcripts. J. Virol. 84:1910344–53
     [Google Scholar]
  115. 115.
    Zhu JY, Strehle M, Frohn A, Kremmer E, Höfig KP et al. 2010. Identification and analysis of expression of novel microRNAs of murine gammaherpesvirus 68. J. Virol. 84:1910266–75
     [Google Scholar]
  116. 116.
    Wu Y-Q, Chen D-J, He H-B, Chen D-S, Chen L-L et al. 2012. Pseudorabies virus infected porcine epithelial cell line generates a diverse set of host microRNAs and a special cluster of viral microRNAs. PLOS ONE 7:e30988
     [Google Scholar]
  117. 117.
    Schäfer A, Cai X, Bilello JP, Desrosiers RC, Cullen BR. 2007. Cloning and analysis of microRNAs encoded by the primate γ-herpesvirus rhesus monkey rhadinovirus. Virology 364:21–27
     [Google Scholar]
  118. 118.
    Kuhn DE, Martin MM, Feldman DS, Terry AV, Nuovo GJ, Elton TS. 2008. Experimental validation of miRNA targets. Methods 44:47–54
     [Google Scholar]
  119. 119.
    Thomson DW, Bracken CP, Goodall GJ. 2011. Experimental strategies for microRNA target identification. Nucleic Acids Res. 39:166845–53
     [Google Scholar]
  120. 120.
    Hafner M, Katsantoni M, Köster T, Marks J, Mukherjee J et al. 2021. CLIP and complementary methods. Nat. Rev. Methods Primers 1:20
     [Google Scholar]
  121. 121.
    Skalsky RL, Kang D, Linnstaedt SD, Cullen BR. 2014. Evolutionary conservation of primate lymphocryptovirus microRNA targets. J. Virol. 88:31617–35
     [Google Scholar]
  122. 122.
    Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature 455:720958–63
     [Google Scholar]
  123. 123.
    Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D et al. 2012. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLOS Pathog. 8:e1002484
     [Google Scholar]
  124. 124.
    Zhao W, Li Q, Sun M, Xiao Y, Cui F. 2022. Interaction between endogenous microRNAs and virus-derived small RNAs controls viral replication in insect vectors. PLOS Pathog. 18:7e1010709
     [Google Scholar]
  125. 125.
    Haecker I, Gay LA, Yang Y, Hu J, Morse AM et al. 2012. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLOS Pathog. 8:8e1002884
     [Google Scholar]
  126. 126.
    Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA. 2012. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 31:92207–21
     [Google Scholar]
  127. 127.
    Paraskevopoulou MD, Karagkouni D, Vlachos IS, Tastsoglou S, Hatzigeorgiou AG. 2018. microCLIP super learning framework uncovers functional transcriptome-wide miRNA interactions. Nat. Commun. 9:3601
     [Google Scholar]
  128. 128.
    Khorshid M, Hausser J, Zavolan M, van Nimwegen E. 2013. A biophysical miRNA-mRNA interaction model infers canonical and noncanonical targets. Nat. Methods 10:3253–55
     [Google Scholar]
  129. 129.
    Erhard F, Dölken L, Jaskiewicz L, Zimmer R. 2013. PARma: identification of microRNA target sites in AGO-PAR-CLIP data. Genome Biol. 14:7R79
     [Google Scholar]
  130. 130.
    Helwak A, Kudla G, Dudnakova T, Tollervey D. 2013. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153:3654–65
     [Google Scholar]
  131. 131.
    Moore MJ, Scheel TKH, Luna JM, Park CY, Fak JJ et al. 2015. miRNA-target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity. Nat. Commun. 6:8864
     [Google Scholar]
  132. 132.
    Gay LA, Sethuraman S, Thomas M, Turner PC, Renne R. 2018. Modified cross-linking, ligation, and sequencing of hybrids (qCLASH) identifies Kaposi's sarcoma-associated herpesvirus microRNA targets in endothelial cells. J. Virol. 92:8e02138–17
     [Google Scholar]
  133. 133.
    Ungerleider N, Bullard W, Kara M, Wang X, Roberts C et al. 2021. EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape. PLOS Pathog. 17:5e1009217
     [Google Scholar]
  134. 134.
    McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N et al. 2019. The biochemical basis of microRNA targeting efficacy. Science 366:6472eaav1741
     [Google Scholar]
  135. 135.
    Paraskevopoulou MD, Georgakilas G, Kostoulas N, Vlachos IS, Vergoulis T et al. 2013. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res. 41:W1W169–73
     [Google Scholar]
  136. 136.
    Gottwein E, Cullen BR. 2008. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3:6375–87
     [Google Scholar]
  137. 137.
    Georgakilas GK, Grioni A, Liakos KG, Chalupova E, Plessas FC, Alexiou P. 2020. Multi-branch convolutional neural network for identification of small non-coding RNA genomic loci. Sci. Rep. 10:9486
     [Google Scholar]
  138. 138.
    Chalupová E, Vaculík O, Poláček J, Jozefov F, Majtner T, Alexiou P 2022. ENNGene: an easy neural network model building tool for genomics. BMC Genom. 23:248
     [Google Scholar]
  139. 139.
    Martinek V, Cechak D, Gresova K, Alexiou P, Simecek P. 2022. Fine-tuning transformers for genomic tasks. bioRxiv 2022.02.07.479412. https://doi.org/10.1101/2022.02.07.479412
  140. 140.
    Ganin Y, Lempitsky V. 2015. Unsupervised domain adaptation by backpropagation. PMLR 37:1180–89
     [Google Scholar]
  141. 141.
    Kozomara A, Birgaoanu M, Griffiths-Jones S. 2019. miRBase: from microRNA sequences to function. Nucleic Acids Res. 47:D1D155–62
     [Google Scholar]
  142. 142.
    Fromm B, Høye E, Domanska D, Zhong X, Aparicio-Puerta E et al. 2022. MirGeneDB 2.1: toward a complete sampling of all major animal phyla. Nucleic Acids Res. 50:D1D204–10
     [Google Scholar]
  143. 143.
    Qureshi A, Thakur N, Monga I, Thakur A, Kumar M. 2014. VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets. Database 2014:bau103
     [Google Scholar]
  144. 144.
    Thakur A, Kumar M. 2022. AntiVIRmiR: a repository of host antiviral miRNAs and their expression along with experimentally validated viral miRNAs and their targets. Front. Genet. 13:971852
     [Google Scholar]
  145. 145.
    Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, Vlachos IS, Tastsoglou S et al. 2018. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res. 46:D1D239–45
     [Google Scholar]
  146. 146.
    Karagkouni D, Paraskevopoulou MD, Tastsoglou S, Skoufos G, Karavangeli A et al. 2019. DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts. Nucleic Acids Res. 48:D101–10
     [Google Scholar]
  147. 147.
    Juzenas S, Lindqvist CM, Ito G, Dolshanskaya Y, Halfvarson J et al. 2020. Depletion of erythropoietic miR-486-5p and miR-451a improves detectability of rare microRNAs in peripheral blood-derived small RNA sequencing libraries. NAR Genom. Bioinform. 2:lqaa008
     [Google Scholar]
  148. 148.
    Moelling K, Broecker F, Russo G, Sunagawa S. 2017. RNase H as gene modifier, driver of evolution and antiviral defense. Front. Microbiol. 8:1745
     [Google Scholar]
  149. 149.
    Decker CJ, Steiner HR, Hoon-Hanks LL, Morrison JH, Haist KC et al. 2019. dsRNA-seq: identification of viral infection by purifying and sequencing dsRNA. Viruses 11:10943
     [Google Scholar]
  150. 150.
    Izumi T, Morioka Y, Urayama S, Motooka D, Tamura T et al. 2021. dsRNA sequencing for RNA virus surveillance using human clinical samples. Viruses 13:71310
     [Google Scholar]
/content/journals/10.1146/annurev-biodatasci-122220-111429
Loading
Virus-Derived Small RNAs and microRNAs in Health and Disease
Annual Review of Biomedical Data Science 6, 275 (2023); https://doi.org/10.1146/annurev-biodatasci-122220-111429
/content/journals/10.1146/annurev-biodatasci-122220-111429
/content/journals/10.1146/annurev-biodatasci-122220-111429
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error